Lisa Dixon is a Professor of Psychiatry at the Columbia University Medical Center and the director of the Division of Behavioral Health Services and Policy Research within the Department of Psychiatry. She also directs the Center for Practice Innovations (CPI) at the New York State Psychiatric Institute.
Dr. Dixon is an internationally recognized health services researcher with over 25 years of continuous funding from the National Institute of Mental Health and the VA. As CPI director, she oversees activities for the New York State Office of Mental Health in implementing evidenced based practices for persons diagnosed with serious mental illness. She is leading the innovative program, OnTrackNY, a statewide initiative designed to improve outcomes and reduce disability for the population of individuals experiencing their first episode of psychosis.
Dr. Dixon's grants have focused on improving the quality of care for individuals with serious mental disorders with a particular emphasis on services that include families, reducing the negative impact of co-occurring addictions and medical problems, and improving treatment engagement and adherence. Dr. Dixon's work has joined individuals engaged in self-help, outpatient psychiatric care, as well as clinicians and policy makers in collaborative research endeavors. In addition, Dr. Dixon is the current editor of a column in Psychiatric Services dedicated to Public-Academic partnerships. She has published more than 200 articles in peer-reviewed journals and received the 2009 American Psychiatric Association Health Services Senior Scholar Award, as well as the Wayne Fenton Award for Exceptional Clinical Care. In 2014, she received the National Alliance on Mental Illness annual Scientific Research Award.
Annette L. Fitzpatrick, PhD, is an epidemiologist and Research Professor in the Departments of Family Medicine, Epidemiology and Global Health and a former Associate Dean in the School of Public Health at the University of Washington, Seattle. She has been working in the field of aging for over 28 years with a focus on cardiovascular disease (CVD) and its risk factors as well as in dementia and cognitive function. She has been Principal Investigator of 18 studies funded by the NIH or CDC as well as co-investigator in an additional 15 studies. She was the first Program Director for the “Cardiovascular Health Study” (CHS), a multi-site cohort developed to understand risk factors of heart disease and stroke in older adults and is a co-investigator for the “Multi-Ethnic Study of Atherosclerosis” (MESA) designed to assess subclinical CVD in adults of White, African-American, Hispanic and Chinese ethnicity. In 2013 she worked with colleagues at Kathmandu University to begin collection of cardiovascular risk factors in the town of Dhulikhel, Nepal, in the “Dhulikhel Heart Study” (DHS). She has published over 170 papers in peer-reviewed journals.
Jaimie L. Gradus
Jaimie L. Gradus is an Associate Professor Epidemiology at Boston University School of Public Health and an Associate Professor of Psychiatry at Boston University School of Medicine. She received her BA in psychology from Stony Brook University, her MPH with a concentration in epidemiology and biostatistics and DSc in epidemiology at Boston University and her DMSc at Aarhus University. Dr. Gradus’s research interests are in the epidemiology of trauma and trauma-related disorders, with a particular focus on suicide outcomes. She was the winner of the 2009 Lilienfeld Student Prize from the Society for Epidemiologic Research for her paper on the association between PTSD and death from suicide in the population of Denmark. Dr. Gradus has been the recipient of multiple National Institute of Mental Health and foundation grant awards to conduct psychiatric epidemiologic research in both veterans and the general population.
Stephen S. Grubbs
Dr. Grubbs joined the American Society of Clinical Oncology (ASCO) in July 2015 as Vice President of the Clinical Affairs Department after 31 years as a practicing medical oncologist in Newark, Delaware at the Helen F. Graham Cancer Center. He served as managing partner of his independent medical practice, Medical Oncology Hematology Consultants, PA.
The ASCO Clinical Affairs department supports practicing oncologists both domestically and internationally through ASCO quality programs, practice business intelligence and support, value-based care consulting, and practice education.
He is a chemical engineering graduate of Purdue University and graduate of the Thomas Jefferson University Medical School. Medical postgraduate training in Internal Medicine was completed at the Medical Center of Delaware and Hematology and Oncology at the Dartmouth Hitchcock Medical Center.
He served as the Principal Investigator of the Delaware Christiana Care NCORP and Board member of the NCI sponsored Alliance cooperative research group. He remains a member for the Alliance Foundation Board and Executive Committee. He is a member of the state of Delaware Cancer Consortium Council and is chair of the Early Detection and Prevention Committee. He is a past member of the ASCO Board of Directors as well as the Ethics, Finance, Research, and Government Relations Committees and past president of the Medical Society of Delaware.
Dr. Grubbs has served as a member of the National Cancer Institute Clinical Trials Advisory Committee, co-chair of the Clinical Trials Subcommittee of the NCI Community Cancer Centers Program (NCCCP), and the Institute of Medicine Committee on Cancer Clinical Trials and the NCI Cooperative Group Program.
He has been an active community based clinical trial investigator with the NCI sponsored CALGB, ECOG, NSABP, and Alliance Cooperative Groups since 1984 and is the recipient of the 2007 Association of Community Cancer Centers David King Community Clinical Scientist Award.
Erin E. Krebs
Erin E. Krebs, MD, MPH is a Core Investigator at the Minneapolis VA Center for Care Delivery and Outcomes Research and Associate Professor of Medicine at the University of Minnesota Medical School. Her research addresses clinical questions related to chronic pain and opioid analgesics, informed by her practice as a primary care physician. She has expertise in comparative effectiveness research and pragmatic trials and has received funding as principal investigator from VA, PCORI, and NIH. Her current research focuses on clinical care and delivery models for patients prescribed long-term opioid therapy for chronic pain. Dr. Krebs completed medical school and internal medicine residency at the University of Minnesota and received her MPH from the University of North Carolina, where she was a Robert Wood Johnson (RWJ) Foundation Clinical Scholar. She completed a VA Career Development Award/RWJ Physician Faculty Scholars Award focused on improving the quality and safety of opioid prescribing in primary care.
Knashawn H. Morales
Knashawn H. Morales is an Associate Professor of Biostatistics in the Department of Biostatistics, Epidemiology, and Informatics at the Perelman School of Medicine at the University of Pennsylvania. Dr. Morales was trained at Harvard School of Public Health, where she earned a doctoral degree in Biostatistcs in 2001. She joined Penn in 2003 after working for the New England Research Institutes. Her methodological research interests include longitudinal data analysis, latent variable modeling, and categorical data analysis. Dr. Morales has extensive collaborative experience in mental health services and clinical trials research. In addition, she has participated in studies involving behavioral modification interventions for asthma, insomnia, HIV/STD risk reduction and weight management. Dr. Morales is the Co-PI of the Penn Mental Health Biostatistics Training Grant and Director of the Penn Mental Health and AIDS Research Center, Biostatistics and Data Management Core. She has produced over 80 collaborative publications including those in high-profile journals such as the Journal of the American Medical Association, Annals of Internal Medicine, the British Medical Journal, and the Journal of the American Statistical Association.
Patricia M. Owens
Ms. Owens has over 30 years of experience in health and disability related programs and policy. She has an unusual set of qualifications having held executive, policy development and administrative positions in both the public and private disability sectors. Her experience serves as the basis for in-depth understanding of the multidimensional and interactive nature of health and disability for individuals and populations in policy formation and risk management. Ms. Owens consults with both public and private organizations on health and disability policy and programs. She is currently a member of the National Academies of Science, Academy of Medicine Standing Committee of Experts on Disability Policy, .
2007- 2011 GOVERNMENT ACCOUNTABILITY OFFICE (GAO)
From September 2007 to September 2011, Ms Owens was the senior disability expert for the Government Accountability Office.
1989 -1999 UNUM INSURANCE COMPANY - Senior Disability Advisor, Vice President; President, Integrated Disability Management (IDM) Division , Vice President, Disability Programs. Provided internal and external consulting and direction on workplace health and disability issues, products and programs. Designed; implemented UNUM’s extensive disability research program including the much-cited research on the Total Cost of Work Disability and Predictors and Descriptors of Psychiatric Disability. Served as President of experimental Integrated Health and Disability Division that developed and tested models that integrated coverage and administration of health, Workers Compensation and short term and long term disability.
1987 - 1989: THE PAUL REVERE INSURANCE GROUP - Vice President, Disability Programs; Vice President of Underwriting. Executive responsibilities included budget, strategic planning, design and implementation of life & disability risk assessment policy; evaluation of experience, development and maintenance of' an expert system for underwriting and customer service. Served as a member of the CEO’s Executive Management Committee that set and monitored company strategic planning
1962 - 1986: THE SOCIAL SECURITY ADMINISTRATION – Associate Commissioner of Disability. As Chief Executive Officer of' the Social Security Disability Program was responsible for all policy, research, operations, administration and evaluation of the Social Security Disability Programs. Played a central role in formulating and lobbying for massive reforms in the program including return to work efforts in cooperation with private employers and insurers. Negotiated cooperative agreements with the American Psychiatric Association, The American Medical Association and various disability advocacy groups. Joined SSA in 1962 and progressed through successively more responsible positions in the field and central office. From late 1979, experience was primarily in the disability programs.
Nina A. Sayer
Nina A. Sayer is the deputy director for the Center for Care Delivery and Outcomes Research at the Minneapolis VA Healthcare System and professor of Medicine and Psychiatry at the University of Minnesota. Dr. Sayer is also a clinical psychologist and a health services researcher whose work focuses on post-deployment health including PTSD, disability, combat-related polytrauma and unmet service needs. Dr. Sayer recieverd her B.A. from Cornell University, her M.A. from New York University, and her Ph.D. in Clinical Psychology also from New York University.
Tisamarie Sherry is an Associate Physician Policy Researcher at the RAND Corporation and a practicing general internist with expertise in health economics, health policy and health services research. Her research evaluates the impacts of public policy and health care system design and financing on health disparities, with a special focus on improving health and economic outcomes for individuals with substance use disorder, psychiatric illness and disabilities. Her recent work examines how chronic illness, pain and opioid use influence health status and functional outcomes. Prior to joining RAND, Sherry worked with the Office of the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services, and with the Centers for Disease Control's Global AIDS Program. She is also a practicing primary care physician at Brigham and Women's Hospital (BWH), and an instructor at Harvard Medical School. Sherry obtained her A.B. in molecular biology and public policy from Princeton University, her M.D. from Harvard Medical School, and Ph.D. in Health Policy from Harvard University. She completed residency training in internal medicine at BWH.
Michael D. Stubblefield is a nationally and internationally recognized leader in the field of cancer rehabilitation. His clinical expertise is in the identification, evaluation and rehabilitation of neuromuscular, musculoskeletal, pain and functional disorders resulting from cancer and its treatment, particularly those caused by radiation and neurotoxic chemotherapy. He is an expert electromyographer and performs procedures such as botulinum toxin (Botox) injections for the relief of pain and spasm in cancer survivors.
Dr. Stubblefield graduated with honors from Brown University in Providence, RI, where he double majored in biology and philosophy. He received his medical degree from the Columbia University College of Physicians and Surgeons and completed a combined residency in internal medicine and physical medicine and rehabilitation (PM&R) at Columbia Presbyterian Medical Center in New York City. He is triple board certified in (PM&R), internal medicine, and electrodiagnostic medicine (EMG).
Dr. Stubblefield worked at Memorial Sloan Kettering Cancer Center for nearly 14 years and was the Chief of the Rehabilitation Medicine Service. He joined Kessler Institute as Medical Director of Cancer Rehabilitation in 2015. He also serves as the National Medical Director of ReVital Cancer Rehabilitation for Select Medical where he oversees the development of comprehensive cancer rehabilitation programs across the organization’s national network of rehabilitation facilities.